These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32750700)

  • 41. Critical care for COVID-19 during a humanitarian crisis-lessons learnt from Yemen.
    Lee JS; Godard A
    Crit Care; 2020 Sep; 24(1):572. PubMed ID: 32972450
    [No Abstract]   [Full Text] [Related]  

  • 42. Prevalence, Characteristics, and Outcome of Asthmatic Patients With Type 2 Diseases in Hospitalized Patients With COVID-19 in Madrid, Spain.
    Barroso B; Valverde-Monge M; Cañas Jose A; Rodrigo-Muñoz JM; Gonzalez-Cano B; Villalobos-Violan V; Betancor D; Gomez-Cardeñosa A; Vallejo-Chamorro G; Baptista-Serna L; Villalobos-Vilda C; Ortega-Martin L; Gómez-López A; Sanchez-Pernaute O; Romero-Bueno F; Rodriguez-Nieto MJ; Del Pozo V; Sastre J;
    J Investig Allergol Clin Immunol; 2020; 30(5):382-384. PubMed ID: 32554336
    [No Abstract]   [Full Text] [Related]  

  • 43. SARS-CoV-2 Infection among Travelers Returning from Wuhan, China.
    Ng OT; Marimuthu K; Chia PY; Koh V; Chiew CJ; De Wang L; Young BE; Chan M; Vasoo S; Ling LM; Lye DC; Kam KQ; Thoon KC; Kurupatham L; Said Z; Goh E; Low C; Lim SK; Raj P; Oh O; Koh VTJ; Poh C; Mak TM; Cui L; Cook AR; Lin RTP; Leo YS; Lee VJM
    N Engl J Med; 2020 Apr; 382(15):1476-1478. PubMed ID: 32163698
    [No Abstract]   [Full Text] [Related]  

  • 44. Strategies for the prevention and management of coronavirus disease 2019.
    Guan WJ; Chen RC; Zhong NS
    Eur Respir J; 2020 Apr; 55(4):. PubMed ID: 32217658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The COVID-19 crisis in South Africa: Protecting the vulnerable.
    Blumberg L; Jassat W; Mendelson M; Cohen C
    S Afr Med J; 2020 Jul; 110(9):825-826. PubMed ID: 32880258
    [No Abstract]   [Full Text] [Related]  

  • 46. A Systems Thinking approach for responding to the COVID-19 pandemic.
    Hassan I; Obaid F; Ahmed R; Abdelrahman L; Adam S; Adam O; Yousif MA; Mohammed K; Kashif T
    East Mediterr Health J; 2020 Aug; 26(8):872-876. PubMed ID: 32896878
    [No Abstract]   [Full Text] [Related]  

  • 47. Tuberculosis and novel Wuhan coronavirus infection: Pathological interrelationship.
    Yasri S; Wiwanitkit V
    Indian J Tuberc; 2020 Apr; 67(2):264. PubMed ID: 32553324
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transparency about death: students on COVID-19.
    Raniolo G; O'Keeffe C; Omrani OA
    Clin Teach; 2020 Aug; 17(4):447-449. PubMed ID: 32815285
    [No Abstract]   [Full Text] [Related]  

  • 49. Two consecutive myocardial tissue insults for inpatients with COVID-19.
    Su M; Peng J; Wu M; Deng W; Yang Y; Peng YG
    Crit Care; 2020 May; 24(1):259. PubMed ID: 32456648
    [No Abstract]   [Full Text] [Related]  

  • 50. Upholding morality and honesty in global scientific research during the coronavirus disease pandemic.
    Lyu P; Wang Y; Hao XY; Liu B; Wei JM
    Chin Med J (Engl); 2020 Oct; 133(20):2401-2402. PubMed ID: 32969864
    [No Abstract]   [Full Text] [Related]  

  • 51. CCR5 Δ32 minorallele is associated with susceptibility to SARS-CoV-2 infection and death: An epidemiological investigation.
    Panda AK; Padhi A; Prusty BAK
    Clin Chim Acta; 2020 Nov; 510():60-61. PubMed ID: 32653483
    [No Abstract]   [Full Text] [Related]  

  • 52. An evidence for correlation between the glutathione S-transferase T1 (GSTT1) polymorphism and outcome of COVID-19.
    Saadat M
    Clin Chim Acta; 2020 Sep; 508():213-216. PubMed ID: 32454047
    [No Abstract]   [Full Text] [Related]  

  • 53. Mortality surveillance during the COVID-19 pandemic.
    Setel P; AbouZahr C; Atuheire EB; Bratschi M; Cercone E; Chinganya O; Clapham B; Clark SJ; Congdon C; de Savigny D; Karpati A; Nichols E; Jakob R; Mwanza J; Muhwava W; Nahmias P; Ortiz EM; Tshangela A
    Bull World Health Organ; 2020 Jun; 98(6):374. PubMed ID: 32514207
    [No Abstract]   [Full Text] [Related]  

  • 54. Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City.
    Miyashita H; Mikami T; Chopra N; Yamada T; Chernyavsky S; Rizk D; Cruz C
    Ann Oncol; 2020 Aug; 31(8):1088-1089. PubMed ID: 32330541
    [No Abstract]   [Full Text] [Related]  

  • 55. Sex and Gender Differences in Health: What the COVID-19 Pandemic Can Teach Us.
    Spagnolo PA; Manson JE; Joffe H
    Ann Intern Med; 2020 Sep; 173(5):385-386. PubMed ID: 32384135
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medical certification of cause of death for COVID-19.
    Rao C
    Bull World Health Organ; 2020 May; 98(5):298-298A. PubMed ID: 32514191
    [No Abstract]   [Full Text] [Related]  

  • 57. Use of "normal" risk to improve understanding of dangers of covid-19.
    Spiegelhalter D
    BMJ; 2020 Sep; 370():m3259. PubMed ID: 32907857
    [No Abstract]   [Full Text] [Related]  

  • 58. Measures of frequency: calculating prevalence and incidence in the era of COVID-19.
    Pizzichini MMM; Patino CM; Ferreira JC
    J Bras Pneumol; 2020 Jun; 46(3):e20200243. PubMed ID: 32556028
    [No Abstract]   [Full Text] [Related]  

  • 59. Real estimates of mortality following COVID-19 infection.
    Baud D; Qi X; Nielsen-Saines K; Musso D; Pomar L; Favre G
    Lancet Infect Dis; 2020 Jul; 20(7):773. PubMed ID: 32171390
    [No Abstract]   [Full Text] [Related]  

  • 60. Guideline for medical certification of death in the COVID-19 era.
    Groenewald P; Awotiwon O; Hanmer L; Bradshaw D
    S Afr Med J; 2020 Jul; 110(8):721-723. PubMed ID: 32880295
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.